An overview of dehydroepiandrosterone (EM-760) as a treatment option for genitourinary syndrome of menopause
Dyspareunia caused by vulvovaginal atrophy is a primary symptom of genitourinary syndrome of menopause (GSM), a chronic, progressive medical condition that results from estrogen and androgen deficiency at menopause.